I have always been a startup guy at heart; I cofounded Xcellerex, helped start up SOTIO Biotech US, and came in early to most of the other companies I have been at. Jeff Goldman and I met during the Xcellerex timeframe, so I was immediately interested when he told me he was starting a new company. As I learned more about Ensorcell’s unique relationship with Re:Build Manufacturing, and their mission to revitalize manufacturing in the US and pass on more savings to its customers, I was sold. Ensorcell is really the best of both worlds: A nimble, ambitious startup made up of seasoned industry veterans who can draw on the engineering and manufacturing expertise of over 1000 professionals in the Re:Build organization, with a shared mission to pass on the benefits of innovation to our customers.
The biggest change over the past two decades has been the introduction of single-use manufacturing. I had a front-row seat for the transition from early skepticism to widespread adoption that made a lot of vendors very successful. Unfortunately, this has also meant that prices of life science tools have steadily risen making them more prohibitive to drug developers and manufacturers. Per the Re:Build Manufacturing ethos, we are working to take a different approach to delivering tools that are sustainably manufactured in the United States and easy to maintain to pass on lifetime savings to end users.
We want to be a driver of the next biomanufacturing revolution, rather than wait to react to it. Bioprocessing plants are going to continue experiencing pressure to be more efficient, driving demand for more productivity per square foot. Flexible changeover and automated operation will be a key driver for facilities of the future. And we are here making a suite of tools that are battery operated (cordless) and portable to enable this future. We are going for simplicity, reliability and longevity.
Our team is taking a long-term view to building a company that provides high-quality products and innovative solutions at reasonable prices, rather than trying to maximize the profit of each product. We believe we will succeed by helping our customers thrive and by sharing with them some of the benefits of our innovation, which is a vision I fully support.
These are not “me too” products, or a product that already exists with some minimal modification. Because we are part of the Re:Build Manufacturing foundation, we have access to a huge team of skilled engineers that examine root causes and truly solve them. We have a single-use focus and are looking ahead to catering to a more automated and flexible facility format that I envision as the next evolution of “ballroom manufacturing” enabled by single-use unit operations.
My career goes back to being in the lab where I spent a lot of time in drug development. And I am not the only one that can say that on the Ensorcell team. Most of us have been in the shoes that our customers are, whether that is in process development or commercial manufacturing environments. This translates to products that are designed, not just with the end user in mind, but by end users. It is unlike any equipment provider currently in the market.
It will always come back to knowing that my work is ultimately helping to treat people in need and saving lives for me. While there is limited ability to be philanthropic as an individual in society unless you are extremely wealthy, having a job like this enables me to expand my impact on the world daily. And with the business model of Ensorcell, as we succeed as a company, we drive further innovation, which is something I feel good about.
